Tuesday, October 8, 2013

Omeros Names VP

Seattle-based biopharmaceuticals firm Omeros announced this morning that it has appointed Michael K. Inouye as its new Vice President, Commercial Operations. Inouye was previously an executive at Pharmacyclics, and also has served at Telik, Gilead Sciences, InSite Vision, and Merck US Human Health, among other companies. Omeros is commercializing small-molecule and protein therapeutics targeting inflammation, coagulopathies and disorders of the central nervous system.